Skip to main content
Partner BE

Research Foundation Flanders

FWO
FWO logo

Organisation

Acronym
FWO
Role
Partner
Country
BE
Address
HOEK 38Leuvenseweg 38,1000 Brussel
Website
https://www.fwo.be/nl/

Programme phases

3

Funding participation

Joint calls funded by this organisation.

10

Funded projects

Projects linked to this funding organisation.

15
ATRTPepVac

Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions

JTC 2013
View project
EPICA

Dual EPigenetic targeting and Immunotherapy to fight against Cancer

JTC 2015
View project
EpiMARK

An integrated approach for epigenetic risk assessment and biomarker development for breast cancer in prospective cohorts / Identifying early epigenetic predictors of breast cancer risk and their etiology determinants

JTC 2012
View project
HEPAMUT

Mutated neo-antigens in hepatocellular carcinoma

JTC 2015
View project
HIGHCARE

High resolution project on prognosis and CARE of cancer patients

JTC 2013
View project
IMMUSPHINX

Targeting sphingolipid metabolism to improve anti-melanoma immune therapies

JTC 2015
View project
INTRACOLOR

Evolution of resistant clones to novel target-directed drugs in colorectal tumors. - A genetic and epigenetic study of intratumoral heterogeneity dynamics

JTC 2014
View project
LIQUIDHOPE

Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastoma

JTC 2017
View project
Ma.Tr.OC

Identification of molecular therapeutic targets and diagnostic/prognostic biomarkers for Malignant Transformation of Osteochondromas

JTC 2012
View project
MAGNOLIA

MAppinG adaptatioN Of tripLe negative breast cancer microenvironments to ImmunotherApy

JTC 2021
View project
ONTHETRRAC

Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe

JTC 2014
View project
PaCaNano

Development of a pancreatic cancer drug-nanocarrier system selectively targeting tumour cells and tumour stroma to overcome treatment failure

JTC 2022
View project
PERIMMUNE

INTRAPERITONEAL IMMUNE MODULATION FOR COLORECTAL PERITONEAL METASTASES

JTC 2021
View project
TRanSLIT

Targeting ROBOs and SLIT guidance cues in the immunosuppressive stromal context of pancreatic cancer (TRanSLIT)

JTC 2021
View project
VALPRAXIN

Validation of Aprataxin as a biomarker of response to Topoisomerase I inhibitors in cancer patient

JTC 2011
View project